A new technique for the induction of plaque formation by Chlamydia trachomatis biovar trachoma applicable to the titration of infectivity and cloning of biovar trachoma was established. Three novel strains were cloned and confirmed to be free of glycogen inclusions. The lack of glycogen accumulation correlated with the absence of a 7.5-kb plasmid, which is highly conserved in other strains of C. trachomatis. Although the growth efficiency of these plasmid-free strains was slightly lower than that of plasmid-positive strains, possession of the plasmid and glycogen accumulation were not essential for the survival of C. trachomatis.
MATERIALS AND METHODS

Chlamydiae
C. psittaci Budgerigar-1 was supplied by the National Institute of Infectious Diseases Japan and was maintained in McCoy cell cultures. C. psittaci Cal 10 has been maintained in our laboratory for more than 25 years in suspension or monolayer cultures of the L929 cell line and has also been well adapted to McCoy cells. C. pneumoniae TW-183 was purchased from the Washington Research Foundation, Seattle, Wash., and was maintained by cultivation in HeLa 229 or HEp-2 cells.
Chlamydia culture. C. trachomatis and C. psittaci were inoculated into McCoy cells, and C. pneumoniae was inoculated into HEp-2 cells. Unless otherwise noted, cell monolayers were prepared in six-well culture plates (Sumitomo Bakelite Co. Ltd., Tokyo, Japan) and were infected by centrifugation in a Beckman GP-type centrifuge (the maximum speed was limited to 2,750 rpm for cell culture plates) at 2,000 rpm (760 ϫ g) for 60 min. The cells were then incubated at 37°C in an atmosphere of 5% CO 2 in minimum essential medium (MEM; Nissui, Tokyo, Japan) containing 1 g of cycloheximide per ml and supplemented with 10% heat-inactivated fetal calf serum (FCS; Gibco BRL Life Technologies Inc., Grand Island, N.Y.).
Plaque formation. The following stock solutions were prepared: (i) 1.1% agarose (SeaKem ME agarose; FMC BioProducts, Rockland, Maine) in distilled water, (ii) phenol red-free 2ϫ Eagle MEM (Nissui), (iii) 100 g of cycloheximide per ml in phosphate-buffered saline (PBS) without Mg and Ca ions [PBS(Ϫ); Nissui], and (iv) 3% neutral red in PBS(Ϫ). All of these solutions except the agarose solution were stored at 4°C after filtration through a 0.2-m-pore-size filter (Millipore Co., Bedford, Mass.); the agarose solution was autoclaved and was kept at room temperature. Just before overlay, the melted agarose solution was mixed with an equal volume of 2ϫ MEM, and the mixture was maintained at 45°C. After the addition of FCS (final concentration, 10%) and cycloheximide (final concentration, 1 g/ml), the agarose medium was overlaid on the infected cell monolayers (2 ml/well). After solidification at room temperature, 1ϫ liquid MEM containing 10% FCS was loaded onto the agarose medium (2 ml/well) and the cultures were incubated at 37°C. The final agarose medium was prepared by adding a 1/100 volume of the neutral red stock solution to the first agarose medium and overlaying it (2 ml/well) on the first agarose medium on the appropriate days postinoculation.
Growth curve. A one-step growth curve for each strain was made as reported previously (28) . Briefly, McCoy cells were infected by centrifugation with appropriately diluted inocula, incubated at 37°C, and then harvested at appropriate times postinoculation. After sonication and brief centrifugation, each supernatant of the cell homogenate was inoculated onto a McCoy cell monolayer on a coverslip (diameter, 14 mm) set in a 24-well cell culture plate (Sumitomo Bakelite Co. Ltd.), and infection was carried out under the conditions described above. Two coverslip cultures for each sample were stained with fluoresceinconjugated monoclonal antibody (MAb) directed against the genus-specific antigen (Chlamydia FA Seiken; Denka Seiken, Tokyo, Japan), and the chlamydial inclusions were then counted. The infectivity (numbers of inclusion-forming units per milliliter) of each sample was calculated from the mean number of inclusions per coverslip.
Quantitation of glycogen. The glycogen in the infected cells was quantified by the anthrone reaction (16) . Infected cells from two wells of a six-well culture plate were carefully suspended in PBS(Ϫ) with a rubber policeman, transferred to a glass centrifuge tube with a tight cap, and then centrifuged at 300 ϫ g for 10 min. After the supernatant was removed, the pellet was stored at Ϫ80°C until use. The pellet was then solubilized in 1 ml of 50% KOH at 100°C for 3 h and cooled at room temperature. Glycogen was then precipitated by the addition of 3 ml of distilled water and 8 ml of ethanol. After washing twice with ice-cold 60% ethanol, the precipitated glycogen was dried in a vacuum desiccator overnight. The precipitate was dissolved in 1 ml of distilled water, and then 5 ml of anthrone solution prepared as described by Hanson and Phillips (16) was added. After thorough mixing, the reaction mixture was allowed to stand for 10 min at 100°C. The color that developed was measured in a spectrophotometer at 625 nm.
Purification of EBs. The elementary body (EB) suspension for extraction of chromosomal and plasmid DNAs was prepared as follows. McCoy cells with well-developed inclusions were collected at 72 h postinoculation and were sonicated to facilitate the release of chlamydial organisms from the host cells. After cell debris was removed by centrifugation at 900 ϫ g for 10 min, the supernatant was layered onto a 25% (wt/vol) sucrose cushion in 30 mM Tris-HCl buffer (pH 7.2, and centrifuged at 8,000 ϫ g for 60 min at 4°C. The pellet obtained was suspended in 0.2 M Tris-HCl buffer (pH 7.2) containing 10 mM MgCl 2 and was then exposed continuously to DNase (20 g/ml), RNase (20 g/ml), and trypsin (100 g/ml) at 37°C for 60 min each. The suspension was then centrifuged again by sucrose-cushioning centrifugation, and the resulting pellet was resuspended in sucrose-phosphate-glutamate (SPG) buffer and stored at Ϫ80°C until it was required for DNA extraction.
For PCR and ligase chain reaction (LCR), a highly purified EB suspension was prepared. The crude EB suspension was layered onto a two-layer cushion; the bottom layer consisted of a 50% (wt/vol) sucrose solution and the top layer consisted of 30% (vol/vol) Urografin (3.5-diacetamido-2,4,6-triisobenzoic acid; Schering AG, Berlin, Germany) in 30 mM Tris-HCl buffer (pH 7.2). It was then centrifuged at 8,000 ϫ g for 60 min. The pellet and turbid bottom layer were suspended in the SPG buffer, and the mixture was then centrifuged at 12,000 ϫ g for 30 min. After resuspension of the pellet in SPG buffer, the suspension was layered onto a continuous Urografin gradient column (40 to 52% [vol/vol] ) and centrifuged at 8,000 ϫ g for 60 min. Next, the EB band in the gradient column was recovered and was diluted with SPG buffer, and the EBs were precipitated by centrifugation at 12,000 ϫ g for 30 min. The EBs obtained were then suspended in 30 mM Tris-HCl buffer and stored at Ϫ80°C. Finally, the number of EBs in the highly purified suspension was counted as described previously (29) .
Preparation and restriction analysis of plasmid and chromosomal DNAs. Plasmid DNA was extracted with the QIAprep Spin Miniprep kit (QIAGEN, Hilden, Germany). On the basis of the results reported by Palmer and Falkow (34) and Peterson et al. (35) , EcoRI was used for restriction fragment analysis. Chromosomal DNA was extracted by the method of Fukushi and Hirai (12) . Briefly, the EBs were treated with proteinase K (200 g/ml) in the presence of 5% 2-mercaptoethanol, 20 mM EDTA, and 0.5% sodium-N-laurylsarcosine at 45°C for 60 min and were then extracted with a mixture of phenol-chloroformisoamyl alcohol (25:24:1). This was followed by treatment with DNase-free RNase A (1 g/ml) at 37°C for 30 min and precipitation with ethanol. The DNA solution was dialyzed against 10 mM Tris-HCl buffer (pH 8.0) containing 1 mM EDTA. BamHI, EcoRI, HindIII, KpnI, PvuII, and SalI were used for restriction fragment length polymorphism analysis. Digestion and electrophoresis of the plasmid and chromosomal DNAs were done by the methods of Sambrook et al. (39) .
PCR and LCR. Both the PCR test kit (AMPLICOR Chlamydia trachomatis; Roche Diagnostic Systems, Branchburg, N.J.) (25) and the LCR test kit (Abbott Laboratories, North Chicago, Ill.) (8) are designed to detect the 7.5-kb plasmid DNA commonly contained in C. trachomatis. We used them to determine if the cloned strains possessed the 7.5-kb plasmid by assaying highly purified EB suspensions as reported previously (30, 31) .
Fluorescence and light microscopies. To simultaneously confirm the C. trachomatis species and examine the inclusion morphology, the infected McCoy cell monolayers on coverslips (diameter, 14 mm) were fixed with ethanol or acetone and stained directly with a fluorescein-conjugated MAb to the species-specific C. trachomatis antigen (MicroTrak; Syva Co., Palo Alto, Calif.). Otherwise, a fluorescein-conjugated MAb to the genus-specific antigen (Chlamydia FA Seiken; Denka Seiken) was used to stain the inclusions of C. trachomatis, C. pneumoniae, and C. psittaci. To determine the level of accumulation of glycogen in the C. trachomatis inclusions, infected McCoy cells were air dried at 40 h postinoculation and were then fixed with methanol for 20 min at room temperature, after which iodine staining was carried out by a method described previously (26) .
Electron microscopy. Infected cells were pelleted by brief centrifugation (300 ϫ g for 3 min) and doubly fixed with 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.3) for 90 min followed by 2.5% OsO4 fixation in the same buffer for 90 min. Thin sections were prepared by a previously reported method (26) and were stained with both uranyl acetate and lead citrate solutions. Plasmid DNA specimens were prepared by the protein surface spreading method described by Griffith (15) . Briefly, the sample suspension was mixed with 0.5 M ammonium acetate (pH 8.0) containing 100 g of cytochrome c (Sigma Chemical Co., St. Louis, Mo.) per ml, and then the mixture was slowly spread down a glass slide onto a 0.01 M ammonium acetate solution. The sample-containing protein film was picked up with a carbon-coated grid and was dehydrated in 90% ethanol. To enhance the plasmid DNA contrast, the grid was shadowcast with a platinum-palladium alloy at an angle of 1:8 on a rotating stage. Both specimens, thin sections and shadow-cast plasmid specimens, were examined with a JEM 2000 EX or a Hitachi H-500 electron microscope at accelerating voltages of 80 and 75 kV, respectively.
RESULTS
Plaque formation. Figure 1 shows plaques of serovar D that formed on day 13 postinoculation. Plaques were clearly seen in the culture wells infected with inocula at dilutions of 10 Ϫ6 and 10 Ϫ7 whereas no plaques were seen in the wells infected with inocula diluted to 10 Ϫ2 and 10
Ϫ3
. In the well infected with an inoculum at a dilution of 10 Ϫ4 , the plaques were extensively fused. Thus, it is clear that the absence of plaques in the first two wells resulted from plaque fusion. All of the serovars and clinical isolates so far tested could form plaques. To form clear plaques, serovar C required 10 days, serovars D, F, H, and L2 required 13 days, and serovar I and the clinical isolates needed 14 days. C. psittaci Cal 10 and Budgerigar-1, on the other hand, formed clear plaques on day 7 postinoculation, and these increased in size, ranging from 4 to 5 mm in diameter by day 13 postinoculation. Consequently, plaque fusion frequently occurred even at infectious doses lower than those for the C. trachomatis strains (data not shown). Figure 2 shows the time course of plaque formation and plaque size. Small plaques were first seen on day 8 postinoculation with the inocula at dilutions of 10 Ϫ5 and 10 Ϫ6 and reached a maximum level on days 12 and 13 for all inocula. The plaque diameter was measured with a magnifying glass with graduations of 0.1 mm. The mean diameter of well-isolated plaques was approximately 0.8 mm on days 10 to 13, but the range of diameters increased each day. A linear correlation between the plaque numbers and inoculum dilution was clearly seen on days 11 to 13 postinoculation.
Cloning of novel strains. A number of single plaques were removed with agar-well punchers (diameter, 2 mm) commonly used to make holes in the Ouchterlony immunodiffusion test. Each agarose plug was sonicated and centrifuged at 300 ϫ g for 5 min, and the supernatant was inoculated onto McCoy cell monolayers on a coverslip as described above. After incubation for 2 days, the McCoy cells were examined by iodine staining and immunostaining. To obtain a pure strain, this cloning procedure was repeated three times for each strain. From serovars D and F and a clinical isolate, we obtained three novel strains with inclusions that did not stain with iodine. Therefore, these strains were designated glycogen-negative strains D-9-3, F4.12t, and Ct-1943-3.1, respectively. In addition, every glycogen-positive strain always produced approximately 1% glycogen-negative inclusions among the glycogen-positive inclusions , and 10
Ϫ7
, respectively. The plate was photographed from the bottom.
even after three successive clonings. To date, we have been unable to isolate any strain which produces 100% glycogen-positive inclusions. Probably, during every replication in a host cell, 1% of the C. trachomatis population loses the glycogen accumulation phenotype. Conversely, the clone producing 100% glycogen-negative inclusions was easily obtained by selecting a glycogen-negative plaque. Nevertheless, we chose D-12N, F4.5N, and Ct-1943-3N as glycogen-positive strains corresponding to the D-9-3, F4.12t, and Ct-1943-3.1 strains, respectively, and examined their biological characteristics. To compare the inclusions from glycogen-negative and glycogen-positive strains in the same microscopic field, the Ct-1943-3.1 and Ct-1943-3N strains were mixed at a ratio of 5:1 and were inoculated into McCoy cell monolayers (Fig. 3 ). There were two types of differently stained inclusions: a densely stained one and a faintly stained one, indicating that the former was of Ct-1943-3N origin and that the latter was of Ct-1943-3.1 origin. The Ct-1943-3.1 inclusion frequently showed a clear zone at the center, a morphology resembling a target-like bull's eye. This unique morphology was readily recognizable under a phase-contrast microscope at 30 h postinoculation. It was also observed in the other glycogen-negative strains, strains D-9-3 and F4.12t. The same morphological features were revealed by immunostaining with both genus-specific and species-specific MAbs (data not shown), and the same results were also obtained by electron microscopy (Fig. 4) . Chlamydial bodies, such as EBs, intermediate forms, and reticulate bodies, were excluded from the large, translucent area, corresponding to the clear zone observed by iodine staining and immunostaining (Fig. 4a) . Many empty vesicles, which appeared to be derived from intermediate forms and EBs because they were smaller in size than reticulate bodies, were noted. Compression of the host nucleus was regularly observed. It should be noted that no glycogen particles were encountered in the glycogen-negative inclusions examined, whereas inclusions of the D-12N, F4.5N, and Ct-1943-3N glycogen-positive strains normally accumulated glycogen (Fig. 4b) .
To confirm biochemically the absence of glycogen accumulation, McCoy cells infected with glycogen-positive or glycogen-negative strains were examined in a timed sequential manner by use of the anthrone reaction (Fig. 5) . The results showed that the magnitude of the reaction in McCoy cells infected with the glycogen-negative strain was just faintly higher than that in noninfected McCoy cells. In contrast, the reaction for a glycogen-positive strain rapidly increased beginning at 18 h postinoculation, even though the number of infected cells was fewer than that for the cells infected with the glycogen-negative strain. The same results were obtained with the D-9-3 and Ct-1943-3.1 strains. The serotypes of the glycogen-negative strains did not differ from those of the parent glycogen-positive strains. The glycogen-negative strains have been stably maintained in our laboratory to date. Growth curve. Glycogen-negative and glycogen-positive strains of the same titer were inoculated into cells, and the growth rates were compared (Fig. 6) . Infectious EB progeny of glycogen-positive strain F4.5N appeared abruptly at 22 h and reached a maximum level at 40 h postinoculation. A similar curve was obtained for glycogen-negative strain F4.12t. However, the EB progeny of F4.12t appeared 3 h after those of F4.5N, and the titer of the former was always slightly lower than that of the latter. The same results were obtained when other glycogen-negative and glycogen-positive strains were compared (data not shown). These results indicated that the growth efficiency of the glycogen-negative strains is slightly lower than that of the glycogen-positive strains under the culture conditions used.
Plasmid and chromosomal DNAs. The electrophoresis of plasmid DNA extracted from approximately 10 8 EBs of the glycogen-positive and glycogen-negative strains is illustrated in Fig. 7 . No band was detected in the lanes loaded with extracts from the glycogen-negative strains, whereas a band of 7.5 kb for an intact plasmid and three fragments of 4.6, 2.5, and 0.4 kb resulting from EcoRI digestion were clearly seen in the lanes with the glycogen-positive strains. The EcoRI fragment pat- VOL. 36, 1998 PLAQUE FORMATION AND PLAQUE CLONING OF C. TRACHOMATIS 3015 terns agreed well with those reported by Palmer and Falkow (34) . These results strongly indicated the absence of the 7.5-kb common plasmid in the glycogen-negative strains. To confirm these results, assays with 10 3 EBs of each strain were done with both PCR and LCR test kits, which were capable of detecting two or more EBs per assay under the experimental conditions used (30, 31) . No positive reaction with the glycogen-negative strains was obtained with either test kit. The results were also confirmed by electron microscopy with 10 8 EBs of each strain. Circular plasmid DNA molecules of about 2 m in length were seen in the extracts of the glycogen-positive strains, whereas no plasmid molecules have been encountered in the samples prepared from the glycogen-negative strains so far examined. When restriction fingerprints of the chromosomal DNAs were examined, no difference was found between the glycogen-positive and glycogen-negative strains (data not shown).
DISCUSSION
Banks et al. (1) suggested that plaque formation by chlamydiae might depend on the strains' growth rates, and consequently, for slowly growing strains such as biovar trachoma long-term maintenance of the cell monolayer in agar medium might be required for plaque formation. In the present study, two points were crucial to the success of plaque formation by biovar trachoma. (i) The liquid culture medium had to be layered onto a solid agarose medium and changed at 4-to 5-day intervals; this treatment may refresh the cells and support chlamydial growth until plaque formation occurs. (ii) The agarose concentration was intentionally reduced to 0.5%, although 1% is the usual concentration for plaque formation by lytic viruses. The reduced agarose concentration may serve to keep the cells in good condition. The quality of the agarose was also important because purified agar was unsuitable for longterm maintenance of the cells. It is also likely that the agarose overlay might create appropriate conditions for the attachment of progeny EBs to host cells by electrostatic interaction (17) and successive adhesion of EBs to host cell receptors (3), followed by endocytosis (20) . Interestingly, cycloheximide in the liquid culture medium did not improve the efficiency of chlamydial replication. It was effective only in the first agarose medium (data not shown).
As shown in Fig. 2 , a linear correlation between the inoculum dilution and plaque number was noted. This indicates that titration of chlamydial inoculum is possible by this technique. However, plaque formation required approximately 2 weeks. This requirement may limit the application of this technique to the titration of EBs, since the infectious titer of EBs can be determined by inclusion counting on day 2 or 3 postinoculation. However, plaque formation by biovar trachoma was very useful for obtaining pure strains. This method enabled us to isolate and characterize three novel glycogen-negative strains, strains D-9-3, F4.12t, and Ct-1943-3. Their inclusions were characterized by a target-like bull's eye morphology that appeared with the formation of a central translucent area that began to be clearly seen at about 30 h postinoculation. This area expanded continuously until the host cell lysed. Chlamydial organisms were excluded from this central area and were pushed to the periphery of the inclusion vacuole. Many envelope-like structures, which might be derived from disintegrated organisms, were seen among intact organisms. Inclusions were round or oval in shape and compressed the host nuclei to the periphery at the late stages of infection, as observed in infections with the parent strains. It is therefore very likely that glycogen accumulation is not essential for the growth of C. trachomatis, although the presence of glycogen is one of the characteristics that differentiates C. trachomatis from the other three chlamydial species (32) .
The 7.5-kb plasmid is believed to encode genes essential for survival of the organisms, since it has been strictly conserved in the species C. trachomatis (5, 34, 41) . However, as shown in the present study, this plasmid was not essential for the growth of C. trachomatis. Peterson et al. (35) also isolated a plasmid-free chlamydia of serovar L2 and reported that the isolate did not contain any detectable plasmid sequence integrated into its chromosome. From these results, it is reasonable to conclude that plasmid-free organisms can be maintained as stable strains. The present study demonstrated a close correlation between the presence of a plasmid and the accumulation of glycogen. Furthermore, the glycogen-positive strains always produced a small population of glycogen-negative inclusions, even after repeated cloning purifications. On the basis of these findings, it can be speculated that the plasmid-free strains possibly arose through omission of plasmids from the plasmid-possessing organisms during replication in host cells.
The entire nucleotide sequence of the 7.5-kb plasmid has been determined (6, 18, 41) , and it has nine open reading frames (ORFs) which can encode for polypeptides of 10 kDa or longer (41) . A 28-kDa protein, the product of ORF 3, has been determined to be a potential immunogen of the outer membranes of C. trachomatis strains that infect humans (7), but the biological function of the plasmid is still unknown. Moulder (33) VOL. 36, 1998 PLAQUE FORMATION AND PLAQUE CLONING OF C. TRACHOMATISfected with C. trachomatis biovar LGV was of the bacterial type. Using the DNASIS homology search program (Hitachi Software Engineering Co. Ltd., Tokyo, Japan), we compared every amino acid sequence translated from each ORF of the 7.5-kb plasmid (6) with those of enzymes involved in bacterial glycogen synthesis (22, 42) but found no significant homology. Thus, it is likely that the glycogen accumulation by C. trachomatis in infected cells is indirectly regulated by an unknown factor(s) encoded by the plasmid. The existence of stable plasmid-free C. trachomatis may cause undesirable problems with diagnosis with PCR and LCR test kits, because the primers in these kits are designed to detect the plasmid. In fact, Farencena et al. (10) recently reported on a clinical isolate of biovar trachoma that lacked the plasmid. Such isolates cannot be detected with current PCR and LCR kits.
In the present study, the growth characteristics of the plasmid-free strains were almost the same as those of the plasmidpositive parent strains in tissue culture systems. However, there is a possibility that the gene products of the 7.5-kb plasmid may be essential for infection of animal organs but not for chlamydial growth in tissue culture systems. Consequently, the pathogenicity of the plasmid-free strains in experimental animals is an important subject for further investigation.
